171808-04-1Relevant articles and documents
Mycophenolic acid as a latent agonist of PPARγ
Ubukata, Makoto,Takamori, Hitomi,Ohashi, Misaki,Mitsuhashi, Shinya,Yamashita, Kaoru,Asada, Tomohisa,Nakajima, Noriyuki,Matsuura, Nobuyasu,Tsuruga, Mie,Taki, Keiko,Magae, Junji
, p. 4767 - 4770 (2008/02/11)
Mycophenolic acid (MPA), known as an inhibitor of inosine monophosphate dehydrogenase (IMPDH), was found to inhibit the differentiation of 3T3-L1 pre-adipocytes into mature adipocytes. Although the effect of MPA was attributed to inhibition of IMPDH, we u
Method of using 4-amino 6-substituted mycophenolic acid and derivatives
-
, (2008/06/13)
The disclosed derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil and other immunosuppressant agents.
Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase by nuclear variants of mycophenolic acid
Nelson, Peter H.,Carr, Stephen F.,Devens, Bruce H.,Eugui, Elsie M.,Franco, Fidencio,Gonzalez, Carlos,Hawley, Ronald C.,Loughhead, David G.,Milan, David J.,Papp, Eva,Patterson, John W.,Rouhafza, Sussan,Sjogren, Eric B.,Smith, David B.,Stephenson, Rebecca A.,Talamas, Francisco X.,Waltos, Ann-Marie,Weikert, Robert J.,Wu, John C.
, p. 4181 - 4196 (2007/10/03)
Structure-activity relationships in the region of the phthalide ring of the inosine monophosphate dehydrogenase inhibitor mycophenolic acid have been explored. Replacement of the lactone ring with other cyclic moieties resulted in loss of potency, especia
6-substituted mycophenolic acid and derivatives
-
, (2008/06/13)
The disclosed 6-substituted derivatives of mycophenolic acid are therapeutic agents advantageous in the treatment of disease states indicated for mycophenolic acid and/or mycophenolate mofetil.